Hawaii Memory Disorders Center & Alzheimer’s Research Unit is Hawaii’s only nationally designated ALZ-NET site to care for patients with memory disorders and part of a network to collaborate and work with other national and global Alzheimer’s centers to improve clinical care to improve detection, diagnosis, and access to treatments and advance innovative research in Alzheimer’s disease.
The center is recognized internationally as well as locally for –
-Dedicated to caring for patients with memory loss by a fully integrated multidisciplinary team of specialists and researchers
-Funded by NIH to conduct research on Alzheimer’s Disease
-Partner with global partners to conduct research to develop better treatments for Alzheimer’s
-First in Hawaii to offer patients any new drugs approved by FDA like Aduhelm and Leqembi (since 2019) and successfully treated and monitor patients for safety
-First in Hawaii to offer patients groundbreaking innovative research treatments in phase I, II, III and IV clinical trials Clinical Trials available at Alzheimer’s Research Unit
-Leader in educating other physicians, residents, medical students, and community in this field Publications by Specialists & Researchers
The evaluation at the memory center will be directed by memory neurologist Dr. Liow working with a multidisciplinary team. Each patient is unique, and medical workups will vary depending on the patient’s medical history and clinical presentation. Once the evaluation for the patient is complete, the multidisciplinary team will discuss the findings with the patient and family. Together we formulate an individualized plan for treatment and management. We understand the challenges of facing these issues. Therefore, we work closely with and support Hawaii’s local support group to be sure you do not feel alone in this journey.
Honolulu, July 2026 A University of Hawai‘i professor and Hawaii neurologist has been asked to serve on the Advisory Council of the International Society to Advance Alzheimer’s Research and Treatment (ISTAART), the professional society of the Alzheimer’s Association. The appointment brings a voice from Hawaii and the Pacific Islands to an international body dedicated to […]
Hawaii Memory Center & Alzheimer’s Research Unit to Present EEG Biomarker Research at the 2026 London AAIC Our team is proud to collaborate with Advanced Brain Monitoring to present new findings at the 2026 Alzheimer’s Association International Conference (AAIC) in London, United Kingdom, July 12–16, 2026. Each year the Alzheimer’s Association International Conference brings together […]
Alzheimer’s Research · Hawaii Memory & Alzheimer’s Research Unit · Published in Nature 2026 University of Hawaii Professor & Researcher Publishes Buntanetap Study in Nature — A Novel Oral Therapy Targeting APP and Tau in Alzheimer’s Disease npj Dementia, Nature · April 2026 · Hawaii Memory & Alzheimer’s Research Unit A landmark study co-authored by […]
Matthew Kobylinski 1 2, Nina Krupa 1 2, Hollis Tam 1, Linda Nguyen 1, Julia R Jahansooz 1 2, Kylie Herndon 1 3, Kaelyn Pacpaco 1 4, Masako Matsunaga 2, Samuel Toh Kim 1, Qi Zhi 1, Michael Sonson 1, 5, Chathura Siriwardhana 2, Enrique Carrazana 2, Kore Liow 1 2 1Memory Disorders Center and […]
Blood Biomarkers, Latest Treatments, and Brain Health Insights Alzheimer’s disease is one of the most talked-about—and misunderstood—neurological conditions today. With constant news headlines, social media discussions, and emerging research, patients and families are often left confused about what is true, what is still being studied, and what actually helps. In a recent episode of KHON2’s […]
DEBUNKING MYTHS, MISINFORMATION, CONTROVERSIES ON ALZHEIMER’S BLOOD BIOMARKERS, LATEST TREATMENTS & BRAIN HEALTH TIPS from US POINTER STUDY. This week on KHON2’s Working For Hawaii: Unscripted, we sat down with Dr. Kore Liow, a neurologist and Alzheimer’s expert, for an educational and insightful conversation to answer the many questions about the disease.
Hawaii Memory & Alzheimer’s Research has joined leading academic institutions—including UCSF, UC San Diego, and the Cleveland Clinic—in a multicenter clinical trial investigating VHB937, a novel TREM2-stabilizing monoclonal antibody engineered to cross the blood–brain barrier and reduce neuroinflammation in Alzheimer’s disease. This collaboration represents an important step in advancing immune-targeted therapies for early Alzheimer’s disease […]
ERP Biomarkers of Cognitive Dysfunction in Alzheimer’s Disease: Real-World Evidence Supporting Translational Clinical Trial Endpoints Advances in neuroscience and digital biomarkers are transforming how clinicians and researchers detect, monitor, and study Alzheimer’s disease (AD). At the 2025 Clinical Trials on Alzheimer’s Disease (CTAD) Conference in San Diego, researchers presented compelling evidence demonstrating how event-related potentials […]
Brainshuttle™ Launched in Hawaii! Novel Alzheimer’s Drug Trontinemab with Brainshuttle™ Technology A new Alzheimer’s clinical study using the investigational drug trontinemab, engineered with Brainshuttle™ technology, is now accepting participants in Hawaii. This approach aims to achieve rapid amyloid clearance with a favourable safety and tolerability profile, including low rates of ARIA (Amyloid Related Imaging Abnormalities). […]
Director, Memory Disorders Center
Principal Investigator, Alzheimer’s Research Unit
Hawaii Pacific Neuroscience
Clinical Professor of Medicine (Neurology), Graduate Faculty, Clinical & Translational Research, University of Hawaii John Burns School of Medicine
Neurology Residency: University of Utah School of Medicine
Fellowship: Cortical Neurophysiology & Clinical Research, NINDS, NIH
Our team is committed to reducing the disparity in health status of its racial and ethnic minority, rural, low-income, and other underserved populations. We have therefore focused our efforts in caring for underserved, minority, diverse patient populations. Click to review our commitment to Diversity, Equity and Inclusion and work undertaken by Center for Neuroscience Diversity especially for the Asian Americans and Native Hawaiian Pacific Islander Population (AANHPI).
Dr Kore Liow is a compassionate doctor, who to my knowledge runs the only research institute in the state of Hawaii for neuroscience issues, particularly related to dementia He has been overseeing my husband's care for the past four years with great attention and concern He assisted us in getting into a two-year clinical trial that I found to have valuable efficacy for my husband's condition He stays on top of all of the national research and technology related to dementia and I am grateful that he maintains the Hawaii Pacific Neuroscience memory disorder center
Laura Greenwood Hawaii